ID
38946
Description
Study ID: 111364 Clinical Study ID: 111364 Study Title: A 28-Day, Polysomnographic and subjective assessment of Vestipitant (15mg/day) for the treatment of Primary Insomnia in adult Outpatients Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00992160 Clinicaltrials.gov Links: https://clinicaltrials.gov/ct2/show/NCT00992160 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Vestipitant, Placebo Trade Name: N/A Study Indication: Primary Insomnia, Sleep Disorders This phase II, placebo-controlled, double-blind trial studies the polysomnographic and subjective effect of the neurokinin (NK1) antagonist vestipitant (15mg/day at bedtime) for the treatment of primary insomnia in adult outpatients over a period of four weeks. The study consists of a clinical Screening Visit (Visit 1), up to 21 days before investigational product/placebo initiation, two screening polysomnographies (Visits 2 and 3), followed by a placebo run-in until Visit 4, at which the subject is randomized to vestipitant or placebo, taken every night for 28 days. On Day 1 and 2 (Visits 4 and 5), polysomnographies are performed. Visit 6 is a safety visit on Day 15. On Day 27 and 28, Visits 7 and 8 are performed, which again include polysomnography studies. Subjects then undergo a 7 to 10 day placebo run-out period and have Day 7 and Day 14 Follow-Up Visit (Visits 9 and 10). This form is used to calculate the subject's median habitual bedtime from their bedtime diary, to decide when the investigational product is to be taken (60 minutes before habitual bedtime). This form is filled in at least 8 days after the Screening Visit (Visit 1), and before Visit 2.
Lien
https://clinicaltrials.gov/ct2/show/NCT00992160
Mots-clés
Versions (3)
- 14/11/2019 14/11/2019 -
- 14/11/2019 14/11/2019 -
- 15/11/2019 15/11/2019 - Sarah Riepenhausen
Détendeur de droits
GlaxoSmithKline
Téléchargé le
15 novembre 2019
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY-NC 3.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Polysomnographic Assessment of Vestipitant for the Treatment of Primary Insomnia NCT00992160
Bedtime Diary - Worksheet for Investigators
- StudyEvent: ODM
Description
Subject Bedtime Diary
Alias
- UMLS CUI-1
- C3890583
- UMLS CUI-2
- C0521112
Description
Fill in itemgroup for seven days.
Type de données
integer
Alias
- UMLS CUI [1,1]
- C3890583
- UMLS CUI [1,2]
- C0439228
- UMLS CUI [1,3]
- C0750480
Description
Diary Entry Date
Type de données
date
Alias
- UMLS CUI [1,1]
- C3890583
- UMLS CUI [1,2]
- C0011008
Description
The "DE:GER (Germany/German)" version of this form uses 24hr format.
Type de données
time
Alias
- UMLS CUI [1,1]
- C0040223
- UMLS CUI [1,2]
- C4740612
- UMLS CUI [1,3]
- C0392223
- UMLS CUI [1,4]
- C0205156
- UMLS CUI [1,5]
- C0240526
Description
The "DE:GER (Germany/German)" version of this form uses 24hr format, and this item is not included in that form.
Type de données
text
Alias
- UMLS CUI [1,1]
- C1521902
- UMLS CUI [1,2]
- C0040223
Description
Bedtimes ranked chronologically
Alias
- UMLS CUI-1
- C0521112
- UMLS CUI-2
- C1705176
Description
Bedtime No.
Type de données
text
Alias
- UMLS CUI [1,1]
- C0521112
- UMLS CUI [1,2]
- C0699794
Description
Bedtime
Type de données
time
Alias
- UMLS CUI [1]
- C0521112
Description
Median Habitual Bedtime
Alias
- UMLS CUI-1
- C0876920
- UMLS CUI-2
- C0205353
- UMLS CUI-3
- C0521112
- UMLS CUI-4
- C1441506
Description
Median of odd number of bedtimes is the bedtime (non-rounded) with equal number of earlier and later times after ranking chronologically; median of even number of bedtimes is mean of 2 middle times after ranking.
Type de données
time
Alias
- UMLS CUI [1,1]
- C0876920
- UMLS CUI [1,2]
- C0205353
- UMLS CUI [1,3]
- C0521112
Description
Call the subject back to schedule the date and time of their arrival at the clinic for their first PSG screening visit. Note: Subjects are to arrive at the clinic in the evening no less than 2 hours before receiving study medication, which is taken 60 minutes before the Median Habitual Bedtime (determined from the Subject Bedtime Diary calculations).
Type de données
time
Alias
- UMLS CUI [1,1]
- C0876920
- UMLS CUI [1,2]
- C0205353
- UMLS CUI [1,3]
- C0521112
- UMLS CUI [1,4]
- C0332232
Description
Print Name
Type de données
text
Alias
- UMLS CUI [1,1]
- C0876920
- UMLS CUI [1,2]
- C0205353
- UMLS CUI [1,3]
- C0521112
- UMLS CUI [1,4]
- C1441506
- UMLS CUI [1,5]
- C2826892
Description
Signature of Investigator calculating Median Habitual Bedtime
Type de données
text
Alias
- UMLS CUI [1,1]
- C0876920
- UMLS CUI [1,2]
- C0205353
- UMLS CUI [1,3]
- C0521112
- UMLS CUI [1,4]
- C1441506
- UMLS CUI [1,5]
- C2346576
Description
Date of Median Habitual Bedtime Calculation
Type de données
date
Alias
- UMLS CUI [1,1]
- C0011008
- UMLS CUI [1,2]
- C0876920
- UMLS CUI [1,3]
- C0205353
- UMLS CUI [1,4]
- C0521112
- UMLS CUI [1,5]
- C1441506
Similar models
Bedtime Diary - Worksheet for Investigators
- StudyEvent: ODM
C2985720 (UMLS CUI [2])
C0439228 (UMLS CUI [1,2])
C0750480 (UMLS CUI [1,3])
C0011008 (UMLS CUI [1,2])
C4740612 (UMLS CUI [1,2])
C0392223 (UMLS CUI [1,3])
C0205156 (UMLS CUI [1,4])
C0240526 (UMLS CUI [1,5])
C1705176 (UMLS CUI-2)
C0205353 (UMLS CUI-2)
C0521112 (UMLS CUI-3)
C1441506 (UMLS CUI-4)
C0205353 (UMLS CUI [1,2])
C0521112 (UMLS CUI [1,3])
C0205353 (UMLS CUI [1,2])
C0521112 (UMLS CUI [1,3])
C0332232 (UMLS CUI [1,4])
C0205353 (UMLS CUI [1,2])
C0521112 (UMLS CUI [1,3])
C1441506 (UMLS CUI [1,4])
C2826892 (UMLS CUI [1,5])
C0205353 (UMLS CUI [1,2])
C0521112 (UMLS CUI [1,3])
C1441506 (UMLS CUI [1,4])
C2346576 (UMLS CUI [1,5])
C0876920 (UMLS CUI [1,2])
C0205353 (UMLS CUI [1,3])
C0521112 (UMLS CUI [1,4])
C1441506 (UMLS CUI [1,5])
Aucun commentaire